Variation of peptide transporter (PepT1 expression in Caco-2 cells as a function and HPT1) of cell origin

被引:51
作者
Behrens, I
Kamm, W
Dantzig, AH
Kissel, T
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
[2] Aventis Pharma Deutschland GmbH, D-65926 Frankfurt, Germany
[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
peptide transport; PepT1; HPT1; Caco-2; cells; cephradine;
D O I
10.1002/jps.20062
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Caco-2 cell cultures area widely used in vitro model for the small intestinal drug transport, although large differences have been reported for actively transported substrates from different laboratories. Therefore, we compared three different Caco-2 clones: (1) from the American Culture Tissue Collection (ATCC), (2) from the German Cancer Research Center (DKFZ) in Heidelberg, and (3) from the University Hospital in Marburg in different passage numbers regarding their morphology, multilayers, and tight junction formation, as well as expression of the peptide transporters, HPT1 and PepT1. We determined tight junction formation by measurement of the transepithelial electrical resistance, multilayer formation by confocal laser scanning microscopy, the expression of PepT1 and HPT1 by RT-PCR, indirect immunofluorescence and the permeability of the PepT1 substrate, cephradine. Morphology and TEER-values varied strongly between the different clones. The expression of PepT1 and HPT1 increased in the following order: HD > ATCC > MR. Indirect immunofluorescence revealed a heterogeneous distribution of the transporters in ATCC-cells, whereas it was homogeneous in HD-cells. Only a very weak expression was found in MR-cells. While in ATCC-cells expression of transporters decreased with increasing passage number, it increased in HD-cells. Expression levels were congruent with the transport of cephradine. Expression of PepT1 and HPT1 was strongly affected by the culture conditions. Under identical culture conditions, Heidelberg (HD) Caco-2 cells seemed to be an appropriate in vitro cell culture model for the transport of actively transported drugs, because interpassage changes are low and the transporter distribution was homogeneous throughout the monolayer. (C) 2004 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:1743 / 1754
页数:12
相关论文
共 28 条
  • [1] PASSIVE DIFFUSION OF WEAK ORGANIC ELECTROLYTES ACROSS CACO-2 CELL MONOLAYERS - UNCOUPLING THE CONTRIBUTIONS OF HYDRODYNAMIC, TRANSCELLULAR, AND PARACELLULAR BARRIERS
    ADSON, A
    BURTON, PS
    RAUB, TJ
    BARSUHN, CL
    AUDUS, KL
    HO, NFH
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (10) : 1197 - 1204
  • [2] A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY
    AMIDON, GL
    LENNERNAS, H
    SHAH, VP
    CRISON, JR
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (03) : 413 - 420
  • [3] SODIUM CAPRATE ELICITS DILATATIONS IN HUMAN INTESTINAL TIGHT JUNCTIONS AND ENHANCES DRUG ABSORPTION BY THE PARACELLULAR ROUTE
    ANDERBERG, EK
    LINDMARK, T
    ARTURSSON, P
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (06) : 857 - 864
  • [4] P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: The influence of culturing conditions and drug exposure on P-gp expression levels
    Anderle, P
    Niederer, E
    Rubas, W
    Hilgendorf, C
    Spahn-Langguth, H
    Wunderli-Allenspach, H
    Merkle, HP
    Langguth, P
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (06) : 757 - 762
  • [5] Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?
    Behrens, I
    Kissel, T
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 (05) : 433 - 442
  • [6] RIBOPROBE EXPRESSION CASSETTES FOR MEASURING IGF-I, BETA-ACTIN AND GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE TRANSCRIPTS
    BIRAGYN, A
    ARKINS, S
    KELLEY, KW
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 168 (02) : 235 - 244
  • [7] BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248
  • [8] ASSOCIATION OF INTESTINAL PEPTIDE-TRANSPORT WITH A PROTEIN RELATED TO THE CADHERIN SUPERFAMILY
    DANTZIG, AH
    HOSKINS, J
    TABAS, LB
    BRIGHT, S
    SHEPARD, RL
    JENKINS, IL
    DUCKWORTH, DC
    SPORTSMAN, JR
    MACKENSEN, D
    ROSTECK, PR
    SKATRUD, PL
    [J]. SCIENCE, 1994, 264 (5157) : 430 - 433
  • [9] TRANSPORT MECHANISMS RESPONSIBLE FOR THE ABSORPTION OF LORACARBEF, CEFIXIME, AND CEFUROXIME AXETIL INTO HUMAN INTESTINAL CACO-2 CELLS
    DANTZIG, AH
    DUCKWORTH, DC
    TABAS, LB
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1994, 1191 (01): : 7 - 13
  • [10] Delie F, 1997, CRIT REV THER DRUG, V14, P221